- Home
- PRLD vs SQNS Comparison
PRLD vs SQNS Comparison
Compare PRLD & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- SQNS
- Stock Information
- Founded
- PRLD 2016
- SQNS 2003
- Country
- PRLD United States
- SQNS France
- Employees
- PRLD N/A
- SQNS N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- SQNS Semiconductors
- Sector
- PRLD Health Care
- SQNS Technology
- Exchange
- PRLD Nasdaq
- SQNS Nasdaq
- Market Cap
- PRLD 48.6M
- SQNS 46.5M
- IPO Year
- PRLD 2020
- SQNS 2011
- Fundamental
- Price
- PRLD $0.78
- SQNS $1.42
- Analyst Decision
- PRLD Strong Buy
- SQNS Strong Buy
- Analyst Count
- PRLD 2
- SQNS 1
- Target Price
- PRLD $4.50
- SQNS $7.50
- AVG Volume (30 Days)
- PRLD 221.0K
- SQNS 1.0M
- Earning Date
- PRLD 08-11-2025
- SQNS 08-22-2025
- Dividend Yield
- PRLD N/A
- SQNS N/A
- EPS Growth
- PRLD N/A
- SQNS N/A
- EPS
- PRLD N/A
- SQNS 2.16
- Revenue
- PRLD $7,000,000.00
- SQNS $38,858,000.00
- Revenue This Year
- PRLD N/A
- SQNS N/A
- Revenue Next Year
- PRLD N/A
- SQNS $93.87
- P/E Ratio
- PRLD N/A
- SQNS $0.66
- Revenue Growth
- PRLD N/A
- SQNS 40.06
- 52 Week Low
- PRLD $0.61
- SQNS $0.95
- 52 Week High
- PRLD $6.80
- SQNS $4.28
- Technical
- Relative Strength Index (RSI)
- PRLD 42.16
- SQNS 36.54
- Support Level
- PRLD $0.77
- SQNS $1.40
- Resistance Level
- PRLD $0.84
- SQNS $1.51
- Average True Range (ATR)
- PRLD 0.07
- SQNS 0.20
- MACD
- PRLD -0.02
- SQNS -0.04
- Stochastic Oscillator
- PRLD 16.04
- SQNS 15.89
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.